Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-06-14

Clinical Trial Update: The Efficacy and Safety of PerioChip Plus (Flurbiprofen/Chlorhexidine) Formulation in the Therapy of Adult Periodontitis [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the efficacy and safety of PerioChip Plus (flurbiprofen/chlorhexidine) for adult periodontitis has been completed. The sponsor was Dexc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PerioChip Plus (flurbiprofen/chlorhexidine)

Snippet

Sponsor: Dexcel Pharma Technologies Ltd. | Conditions: Periodontitis | Phase 2 | Status: COMPLETED